BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) Portfolio Manager Christopher Accettella acquired 1,190 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Thursday, January 11th. The stock was acquired at an average price of 15.17 per share, with a total value of 18,052.30. Following the completion of the purchase, the portfolio manager now directly owns 4,070 shares in the company, valued at 61,741.90. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.
BlackRock Health Sciences Term Trust Price Performance
Shares of BlackRock Health Sciences Term Trust stock traded up 0.13 during trading hours on Friday, reaching 15.89. The company had a trading volume of 222,500 shares, compared to its average volume of 274,693. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.59. The business has a fifty day simple moving average of 15.85 and a 200 day simple moving average of 15.53.
BlackRock Health Sciences Term Trust Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be issued a dividend of $0.176 per share. This represents a $2.11 dividend on an annualized basis and a yield of 13.29%. The ex-dividend date is Tuesday, October 15th.
Institutional Investors Weigh In On BlackRock Health Sciences Term Trust
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- How to Calculate Stock Profit
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.